These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major. Shazad B; Abbaszadeh B; Khamesipour A Eur J Dermatol; 2005; 15(2):85-7. PubMed ID: 15757817 [TBL] [Abstract][Full Text] [Related]
9. Fluconazole for the treatment of cutaneous leishmaniasis. Zvulunov A; Klaus S; Vardy D N Engl J Med; 2002 Aug; 347(5):370-1; author reply 370-1. PubMed ID: 12151480 [No Abstract] [Full Text] [Related]
11. Unsuccessful treatment of cutaneous leishmaniasis by Leishmania infantum with topical paromomycin. Veraldi S; Benzecry Mancin V; Faraci AG; Nazzaro G Int J Dermatol; 2020 Jul; 59(7):e251-e252. PubMed ID: 31975375 [No Abstract] [Full Text] [Related]
12. Successful Treatment of Cutaneous Leishmaniasis with Topical Paramomycin in a Child After Treatment Failure with Systemic Fluconazole. Chacko A; Joseph M; Feltis T; Morris SK Am J Trop Med Hyg; 2016 Oct; 95(4):793-794. PubMed ID: 27549634 [TBL] [Abstract][Full Text] [Related]
13. Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment of American cutaneous leishmaniasis: controlled study. Krause G; Kroeger A Clin Infect Dis; 1999 Aug; 29(2):466-7. PubMed ID: 10476776 [No Abstract] [Full Text] [Related]
14. Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran. Asilian A; Jalayer T; Nilforooshzadeh M; Ghassemi RL; Peto R; Wayling S; Olliaro P; Modabber F Bull World Health Organ; 2003; 81(5):353-9. PubMed ID: 12856053 [TBL] [Abstract][Full Text] [Related]
15. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin. Grogl M; Schuster BG; Ellis WY; Berman JD J Parasitol; 1999 Apr; 85(2):354-9. PubMed ID: 10219319 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of a combination of paromomycin and miltefosine for two vs. three courses in patients with post-kala-azar dermal leishmaniasis: an observational pilot study. Pandey K; Pal B; Das VNR; Murti K; Lal CS; Verma N; Bimal S; Ali V; Verma RB; Topno RK; Siddiqi NA; Das P Br J Dermatol; 2017 Aug; 177(2):557-559. PubMed ID: 27781268 [No Abstract] [Full Text] [Related]
17. Non-ulcerative cutaneous leishmaniasis in Honduras fails to respond to topical paromomycin. Neva FA; Ponce C; Ponce E; Kreutzer R; Modabber F; Olliaro P Trans R Soc Trop Med Hyg; 1997; 91(4):473-5. PubMed ID: 9373659 [TBL] [Abstract][Full Text] [Related]